GSK plc
GLAXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $54,870,634 | $59,626,067 | $58,211,161 | $64,782,756 |
| - Cash | $3,693,000 | $2,936,000 | $3,723,000 | $4,274,000 |
| + Debt | $16,986,000 | $18,018,000 | $20,987,000 | $24,173,000 |
| Enterprise Value | $68,163,634 | $74,708,067 | $75,475,161 | $84,681,756 |
| Revenue | $31,376,000 | $30,328,000 | $29,324,000 | $34,114,000 |
| % Growth | 3.5% | 3.4% | -14% | – |
| Gross Profit | $22,328,000 | $21,763,000 | $19,770,000 | $22,511,000 |
| % Margin | 71.2% | 71.8% | 67.4% | 66% |
| EBITDA | $6,668,000 | $9,083,000 | $8,601,000 | $6,485,000 |
| % Margin | 21.3% | 29.9% | 29.3% | 19% |
| Net Income | $2,575,000 | $4,928,000 | $14,956,000 | $4,385,000 |
| % Margin | 8.2% | 16.2% | 51% | 12.9% |
| EPS Diluted | 0.62 | 1.2 | 3.66 | 1.35 |
| % Growth | -48.3% | -67.2% | 171.1% | – |
| Operating Cash Flow | $6,554,000 | $6,768,000 | $7,403,000 | $7,952,000 |
| Capital Expenditures | -$2,982,000 | -$2,344,000 | -$2,258,000 | -$2,931,000 |
| Free Cash Flow | $3,572,000 | $4,424,000 | $5,145,000 | $5,021,000 |